EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW)

CUSIP: 28202V116

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / *W EXP 12/31/202
Total 13F shares
638,163
Share change
-15,515
Total reported value
$98,934
Price per share
$0.16
Number of holders
8
Value change
-$4,400
Number of buys
3
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 28202V116?
CUSIP 28202V116 identifies EFTRW - EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) as of Q4 2022

As of 31 Dec 2022, EFFECTOR THERAPEUTICS INC - *W EXP 12/31/202 (EFTRW) was held by 8 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 638,163 shares. The largest 8 holders included WHITEBOX ADVISORS LLC, MMCAP International Inc. SPC, Parallel Advisors, LLC, Evolution Capital Management LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CITADEL ADVISORS LLC, WOLVERINE ASSET MANAGEMENT LLC, and Jefferies Financial Group Inc.. This page lists 8 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.